Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. MOH
stocks logo

MOH

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
10.92B
+3.97%
0.640
-87.33%
11.62B
+4.28%
4.450
-26.81%
11.81B
+3.37%
3.884
-29.13%
Estimates Revision
The market is revising Upward the revenue expectations for Molina Healthcare, Inc. (MOH) for FY2025, with the revenue forecasts being adjusted by 0.67% over the past three months. During the same period, the stock price has changed by -11.86%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.67%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-24.7%
In Past 3 Month
Stock Price
Go Down
down Image
-11.86%
In Past 3 Month
Wall Street analysts forecast MOH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MOH is 170.36 USD with a low forecast of 144.00 USD and a high forecast of 220.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
Wall Street analysts forecast MOH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MOH is 170.36 USD with a low forecast of 144.00 USD and a high forecast of 220.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
8 Hold
2 Sell
Hold
Current: 150.570
sliders
Low
144.00
Averages
170.36
High
220.00
Current: 150.570
sliders
Low
144.00
Averages
170.36
High
220.00
Wells Fargo
Overweight
downgrade
$231 -> $165
2025-11-12
Reason
Wells Fargo
Price Target
$231 -> $165
2025-11-12
downgrade
Overweight
Reason
Wells Fargo lowered the firm's price target on Molina Healthcare to $165 from $231 and keeps an Overweight rating on the shares following disappointing Q3 results. While Medicaid remains uncertain in 2026 / 2027, the firm thinks annualized returns as margins begin to recover are fairly interesting at these levels.
TD Cowen
Hold
downgrade
$203 -> $175
2025-10-27
Reason
TD Cowen
Price Target
$203 -> $175
2025-10-27
downgrade
Hold
Reason
TD Cowen lowered the firm's price target on Molina Healthcare to $175 from $203 and keeps a Hold rating on the shares. The firm updated its model following revised 2025 guidance with HIX pressure a material driver.
UBS
Neutral
downgrade
$180 -> $170
2025-10-24
Reason
UBS
Price Target
$180 -> $170
2025-10-24
downgrade
Neutral
Reason
UBS lowered the firm's price target on Molina Healthcare to $170 from $180 and keeps a Neutral rating on the shares.
Morgan Stanley
Erin Wright
Equal Weight
downgrade
$204 -> $158
2025-10-24
Reason
Morgan Stanley
Erin Wright
Price Target
$204 -> $158
2025-10-24
downgrade
Equal Weight
Reason
Morgan Stanley analyst Erin Wright lowered the firm's price target on Molina Healthcare to $158 from $204 and keeps an Equal Weight rating on the shares after lowering the firm's FY25 and FY26 EPS estimates following the company's Q3 miss and third guidance cut since July.
Truist
Hold
downgrade
$210 -> $175
2025-10-24
Reason
Truist
Price Target
$210 -> $175
2025-10-24
downgrade
Hold
Reason
Truist lowered the firm's price target on Molina Healthcare to $175 from $210 and keeps a Hold rating on the shares. The company posted challenging Q3 results where ongoing medical cost pressures resulted in an adjusted EPS miss while FY25 guidance was cut, with initial FY26 comments pointing to earnings similar to FY25 levels, the analyst tells investors in a research note. Medicaid commentary was constructive however relative to the difficult environment, the firm added.
Barclays
Equal Weight -> Underweight
downgrade
$185 -> $144
2025-10-24
Reason
Barclays
Price Target
$185 -> $144
2025-10-24
downgrade
Equal Weight -> Underweight
Reason
Barclays downgraded Molina Healthcare to Underweight from Equal Weight with a price target of $144, down from $185. The firm thinks the company's preliminary 2026 earnings per share outlook of $14 is "too optimistic," assuming its Medicaid medical loss ratio will be flat year-over-year. Despite Molina's "disappointing" Q3 results and corresponding stock selloff, there remains downside risk to forward estimates, the analyst tells investors in a research note. Barclays views the company's building Medicaid pressure in the second half of 2025 as a "clear negative development" for 2026.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Molina Healthcare Inc (MOH.N) is 12.44, compared to its 5-year average forward P/E of 15.06. For a more detailed relative valuation and DCF analysis to assess Molina Healthcare Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
15.06
Current PE
12.44
Overvalued PE
17.65
Undervalued PE
12.47

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
8.82
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
10.33
Undervalued EV/EBITDA
7.31

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.49
Current PS
0.00
Overvalued PS
0.60
Undervalued PS
0.38
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

MOH News & Events

Events Timeline

(ET)
2025-11-25
06:20:32
Speaker Johnson cautions that House Republicans oppose ACA subsidies, according to WSJ.
select
link
2025-11-24 (ET)
2025-11-24
14:11:55
White House Delays Healthcare Proposal Following Backlash, Reports MS Now
select
link
2025-11-24
06:47:07
White House anticipated to announce continuation of Obamacare subsidies, according to Politico.
select
link
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.0
01:22 AMGlobenewswire
Cytokinetics Faces Shareholder Claims Over Executive Misconduct
  • Shareholder Claims Investigation: Grabar Law Office is investigating whether Cytokinetics' executives breached their fiduciary duties, allowing shareholders who purchased shares before December 27, 2023, to seek corporate reforms and fund recovery.
  • FDA Approval Delay: On May 1, 2025, Cytokinetics announced that the FDA extended the review date for aficamten's NDA from September 26, 2025, to December 26, 2025, due to the omission of a Risk Evaluation and Mitigation Strategy in the initial filing, causing significant shareholder harm.
  • False Statement Allegations: Executives are accused of misleading investors by stating on March 10, 2025, that the FDA would not convene an advisory committee meeting, leading to incorrect assessments of the company's prospects and negatively impacting stock prices.
  • Severe Market Reaction: These allegations have left Cytokinetics' shareholders facing potential financial losses, severely undermining market confidence in the company's future and possibly leading to further declines in stock value.
[object Object]
Preview
5.0
12-04NASDAQ.COM
Cobalt Capital Makes Significant Investment in Molina Healthcare Following Recent Decline

  • Cobalt Capital Management's Investment: Cobalt Capital Management acquired 115,000 shares of Molina Healthcare, Inc. (NYSE:MOH) valued at approximately $22 million, making it the fund's 4th-largest holding and representing 10.11% of its 13F reportable assets.

  • Molina Healthcare Overview: Molina Healthcare provides managed healthcare services primarily through government-sponsored programs like Medicaid and Medicare, serving around 5.2 million members across 18 U.S. states as of December 31, 2021.

  • Market Performance and Investor Sentiment: Despite a significant decline in stock price, Cobalt Capital's investment suggests a belief that the market has misjudged Molina's financial stability and potential for recovery, particularly as the company navigates pricing and cost management.

  • Future Outlook: Investors are focused on how Molina Healthcare will adjust its pricing and restore margins as new contracts are implemented, with the potential for current valuations to represent an opportunity rather than a warning.

[object Object]
Preview
7.0
12-03Globenewswire
Five Below (FIVE) Class Action Survives Dismissal Motion Amid Securities Fraud Allegations
  • Lawsuit Survival: Five Below's shareholder class action survives a motion to dismiss, as the court found that plaintiffs plausibly allege misleading information regarding the company's financial health and operations, potentially leading to corporate reforms and fund recovery.
  • Financial Transparency Issues: The lawsuit alleges that executives failed to disclose serious issues related to inventory management and market trends, which not only undermines investor confidence but could also lead to future performance declines.
  • Shareholder Rights Protection: Shareholders holding Five Below stock can seek court-approved incentive awards at no cost, a move that may encourage more shareholders to participate in the lawsuit, increasing pressure on corporate governance.
  • Potential Market Impact: As the lawsuit progresses, Five Below may face greater market pressure, with investor confidence in its future financial performance likely to wane, potentially affecting stock price performance.
Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Molina Healthcare Inc (MOH) stock price today?

The current price of MOH is 150.57 USD — it has increased 0.99 % in the last trading day.

arrow icon

What is Molina Healthcare Inc (MOH)'s business?

Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. Medicaid provides healthcare and long-term services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over, and some disabled persons, with a variety of hospital, medical insurance, and prescription drug benefits. The Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. It arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies.

arrow icon

What is the price predicton of MOH Stock?

Wall Street analysts forecast MOH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MOH is 170.36 USD with a low forecast of 144.00 USD and a high forecast of 220.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Molina Healthcare Inc (MOH)'s revenue for the last quarter?

Molina Healthcare Inc revenue for the last quarter amounts to 11.48B USD, increased 11.00 % YoY.

arrow icon

What is Molina Healthcare Inc (MOH)'s earnings per share (EPS) for the last quarter?

Molina Healthcare Inc. EPS for the last quarter amounts to 1.50 USD, decreased -73.45 % YoY.

arrow icon

What changes have occurred in the market's expectations for Molina Healthcare Inc (MOH)'s fundamentals?

The market is revising Upward the revenue expectations for Molina Healthcare, Inc. (MOH) for FY2025, with the revenue forecasts being adjusted by 0.67% over the past three months. During the same period, the stock price has changed by -11.86%.
arrow icon

How many employees does Molina Healthcare Inc (MOH). have?

Molina Healthcare Inc (MOH) has 18000 emplpoyees as of December 05 2025.

arrow icon

What is Molina Healthcare Inc (MOH) market cap?

Today MOH has the market capitalization of 7.74B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free